journal article·2017-04-12

Thiol-Reactive Star Polymers Display Enhanced Association with Distinct Human Blood Components

Joshua J. Glass, Yang Li, Robert De Rose, Angus P. R. Johnston, Ewa I. Czuba, Song Yang Khor, John F. Quinn, Michael R. Whittaker, Thomas P. Davis, Stephen J. Kent

Publisher page

Abstract

Directing nanoparticles to specific cell types using nonantibody-based methods is of increasing interest. Thiol-reactive nanoparticles can enhance the efficiency of cargo delivery into specific cells through interactions with cell-surface proteins. However, studies to date using this technique have been largely limited to immortalized cell lines or rodents, and the utility of this technology on primary human cells is unknown. Herein, we used RAFT polymerization to prepare pyridyl disulfide (PDS)-functionalized star polymers with a methoxy-poly(ethylene glycol) brush corona and a fluorescently labeled cross-linked core using an arm-first method. PDS star polymers were examined for their interaction with primary human blood components: six separate white blood cell subsets, as well as red blood cells and platelets. Compared with control star polymers, thiol-reactive nanoparticles displayed enhanced association with white blood cells at 37 °C, particularly the phagocytic monocyte, granulocyte, and dendritic cell subsets. Platelets associated with more PDS than control nanoparticles at both 37 °C and on ice, but they were not activated in the duration examined. Association with red blood cells was minor but still enhanced with PDS nanoparticles. Thiol-reactive nanoparticles represent a useful strategy to target primary human immune cell subsets for improved nanoparticle delivery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria 3010, Australia

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia

Department of Chemistry, University of Warwick, Gibbet Hill, Coventry CV4 7AL, United Kingdom

Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Health, Central Clinical School, Monash University, Melbourne, Victoria 3800, Australia

Funding

Australian Research Council · Centre of Excellence in Convergent Bio-Nano Science and Technology, Australian Research Council

References (63)

Show source-provided references
1. 10.1016/j.addr.2004.02.01410.1016/j.addr.2004.02.014 ↗
2. 10.1073/pnas.101838210810.1073/pnas.1018382108 ↗
3. 10.1073/pnas.08162689810.1073/pnas.081626898 ↗
4. Lawrence D. A. · J. Leukocyte Biol. · 1996 · 60 · 61110.1002/jlb.60.5.611 ↗
5. 10.1073/pnas.262803210010.1073/pnas.2628032100 ↗
6. 10.1002/adma.20110160910.1002/adma.201101609 ↗
7. 10.1016/j.tibtech.2011.12.00210.1016/j.tibtech.2011.12.002 ↗
8. 10.1002/ijc.2370910.1002/ijc.23709 ↗
9. Pendyala L. · Clin. Cancer Res. · 1997 · 3 · 793
10. 10.1038/sj.bjc.669079710.1038/sj.bjc.6690797 ↗
11. 10.1038/nm.219810.1038/nm.2198 ↗
12. 10.4049/jimmunol.140253510.4049/jimmunol.1402535 ↗
13. 10.1038/nri372710.1038/nri3727 ↗
14. 10.1038/nrcardio.2011.9110.1038/nrcardio.2011.91 ↗
15. 10.1021/nn506157810.1021/nn5061578 ↗
16. 10.1002/adma.20080182610.1002/adma.200801826 ↗
17. 10.2217/nnm.12.11110.2217/nnm.12.111 ↗
18. 10.1039/C6PY01332E10.1039/C6PY01332E ↗
19. 10.1021/acs.chemrev.6b0000810.1021/acs.chemrev.6b00008 ↗
20. 10.1002/marc.20120002910.1002/marc.201200029 ↗
21. 10.1021/mp400049e10.1021/mp400049e ↗
22. 10.1039/C0CC04532B10.1039/C0CC04532B ↗
23. 10.1039/c1py00102g10.1039/c1py00102g ↗
24. 10.1016/j.nano.2015.08.00110.1016/j.nano.2015.08.001 ↗
25. 10.1002/adhm.20140016410.1002/adhm.201400164 ↗
26. 10.1016/j.xphs.2015.11.03810.1016/j.xphs.2015.11.038 ↗
27. 10.1002/marc.20060069310.1002/marc.200600693 ↗
28. 10.1021/mz400437510.1021/mz4004375 ↗
29. 10.1039/c1py00071c10.1039/c1py00071c ↗
30. 10.1002/0471142956.cy1017s5310.1002/0471142956.cy1017s53 ↗
31. 10.1038/nbt.259410.1038/nbt.2594 ↗
32. 10.1016/j.tox.2009.08.01110.1016/j.tox.2009.08.011 ↗
33. 10.1055/s-0035-157008210.1055/s-0035-1570082 ↗
34. 10.1021/mp200463e10.1021/mp200463e ↗
35. 10.1126/science.124114510.1126/science.1241145 ↗
36. 10.1038/nrc393010.1038/nrc3930 ↗
37. 10.1001/jamaoncol.2016.457410.1001/jamaoncol.2016.4574 ↗
38. 10.1016/j.addr.2016.02.00710.1016/j.addr.2016.02.007 ↗
39. Shemin D. · J. Biol. Chem. · 1946 · 166 · 62710.1016/S0021-9258(17)35201-8 ↗
40. 10.1182/blood-2011-07-35600610.1182/blood-2011-07-356006 ↗
41. 10.1021/jm901876r10.1021/jm901876r ↗
42. 10.1021/bc050146t10.1021/bc050146t ↗
43. 10.1016/S0169-409X(02)00179-510.1016/S0169-409X(02)00179-5 ↗
44. 10.1021/acs.biomac.5b0157110.1021/acs.biomac.5b01571 ↗
45. 10.1021/bc900444310.1021/bc9004443 ↗
46. 10.1071/CH0906210.1071/CH09062 ↗
47. 10.1002/pola.2390210.1002/pola.23902 ↗
48. 10.1002/marc.20110012710.1002/marc.201100127 ↗
49. Essex D. W. · Blood · 1995 · 86 · 216810.1182/blood.V86.6.2168.bloodjournal8662168 ↗
50. 10.1074/jbc.274.4.241610.1074/jbc.274.4.2416 ↗
51. 10.1016/j.ejpb.2013.02.01010.1016/j.ejpb.2013.02.010 ↗
52. 10.1016/j.jconrel.2014.11.02710.1016/j.jconrel.2014.11.027 ↗
53. 10.1016/j.jconrel.2014.03.05010.1016/j.jconrel.2014.03.050 ↗
54. 10.1021/nn404853z10.1021/nn404853z ↗
55. 10.1016/j.immuni.2012.12.00110.1016/j.immuni.2012.12.001 ↗
56. 10.1038/nri307010.1038/nri3070 ↗
57. 10.1182/blood-2004-03-110910.1182/blood-2004-03-1109 ↗
58. 10.1038/nnano.2014.6210.1038/nnano.2014.62 ↗
59. 10.1016/j.biomaterials.2012.02.02210.1016/j.biomaterials.2012.02.022 ↗
60. 10.4049/jimmunol.090027410.4049/jimmunol.0900274 ↗
61. 10.1007/s12645-012-0029-910.1007/s12645-012-0029-9 ↗
62. Harker L. A. · Blood · 2000 · 95 · 251410.1182/blood.V95.8.2514 ↗
63. 10.1021/nn503732m10.1021/nn503732m ↗